Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE).

Bower JK, Pankow JS, Lazo M, Christenson E, Hoogeveen RC, Ballantyne CM, Halushka MK, Astor BC, Selvin E.

Clin Biochem. 2014 Jan;47(1-2):132-4. doi: 10.1016/j.clinbiochem.2013.11.005. Epub 2013 Nov 15.

2.

sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.

Al Rifai M, Schneider AL, Alonso A, Maruthur N, Parrinello CM, Astor BC, Hoogeveen RC, Soliman EZ, Chen LY, Ballantyne CM, Halushka MK, Selvin E.

J Diabetes Complications. 2015 Mar;29(2):180-5. doi: 10.1016/j.jdiacomp.2014.11.008. Epub 2014 Nov 25.

3.

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.

Cheng Y, Zhong J, Xiang Y, Zeng F, Cai D, Zhao L.

Clin Interv Aging. 2014 Nov 19;9:1981-6. doi: 10.2147/CIA.S71130. eCollection 2014.

4.

Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.

Rebholz CM, Astor BC, Grams ME, Halushka MK, Lazo M, Hoogeveen RC, Ballantyne CM, Coresh J, Selvin E.

Nephrol Dial Transplant. 2015 Jan;30(1):77-83. doi: 10.1093/ndt/gfu282. Epub 2014 Aug 21.

5.

Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: the Northern Manhattan Study.

Hudson BI, Dong C, Gardener H, Elkind MS, Wright CB, Goldberg R, Sacco RL, Rundek T.

Metabolism. 2014 Sep;63(9):1125-30. doi: 10.1016/j.metabol.2014.05.011. Epub 2014 Jun 4.

6.

Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.

Davis KE, Prasad C, Vijayagopal P, Juma S, Imrhan V.

Nutr Res. 2014 Jun;34(6):478-85. doi: 10.1016/j.nutres.2014.04.012. Epub 2014 Apr 24.

PMID:
25026914
7.

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

Geroldi D, Falcone C, Emanuele E, D'Angelo A, Calcagnino M, Buzzi MP, Scioli GA, Fogari R.

J Hypertens. 2005 Sep;23(9):1725-9.

PMID:
16093918
8.

Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.

Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ.

Coron Artery Dis. 2009 Jun;20(4):267-73. doi: 10.1097/MCA.0b013e32832c459c.

PMID:
19440065
9.

Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.

Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH.

Atherosclerosis. 2012 Jan;220(1):208-14. doi: 10.1016/j.atherosclerosis.2011.07.115. Epub 2011 Aug 5.

PMID:
21906738
10.

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M, Sacco RL, DeCarli C, Wright CB, Elkind MS.

Atherosclerosis. 2011 May;216(1):192-8. doi: 10.1016/j.atherosclerosis.2011.01.024. Epub 2011 Jan 21.

11.

Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.

Yu Y, Hanssen KF, Kalyanaraman V, Chirindel A, Jenkins AJ, Nankervis AJ, Torjesen PA, Scholz H, Henriksen T, Lorentzen B, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Wu M, Basu A, Aston CE, Lyons TJ.

BJOG. 2012 Nov;119(12):1512-20. doi: 10.1111/j.1471-0528.2012.03463.x. Epub 2012 Aug 20.

12.

Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.

Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2009 Nov 15;180(10):1010-5. doi: 10.1164/rccm.200901-0118OC. Epub 2009 Aug 6.

13.

Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.

Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G, Heine RJ, 't Hart LM, de Groot PG, Stehouwer CD, Schalkwijk CG.

J Clin Endocrinol Metab. 2009 Dec;94(12):5174-80. doi: 10.1210/jc.2009-1067. Epub 2009 Nov 4.

PMID:
19890027
14.

Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents.

Park HJ, Seo SM, Shin WS, Kim HY, Choi YS, Koh YS, Youn SG, Park MW, Chang K, Kim PJ, Jung HO, Baek SH, Chung WS, Seung KB, Yoo KD.

Coron Artery Dis. 2011 Jan;22(1):12-7.

PMID:
21197704
15.

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferrannini E, Gastaldelli A.

J Clin Endocrinol Metab. 2006 Nov;91(11):4628-34. Epub 2006 Aug 22.

PMID:
16926247
16.

Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.

Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, Coresh J, Selvin E, Kao WH.

PLoS One. 2015 Jun 17;10(6):e0128452. doi: 10.1371/journal.pone.0128452. eCollection 2015.

17.

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.

Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL.

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):129-34. doi: 10.1016/j.numecd.2008.03.004. Epub 2008 Jul 2.

PMID:
18595673
18.

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.

Isoyama N, Leurs P, Qureshi AR, Bruchfeld A, Anderstam B, Heimburger O, Bárány P, Stenvinkel P, Lindholm B.

Nephrol Dial Transplant. 2015 Jan;30(1):84-91. doi: 10.1093/ndt/gfu259. Epub 2014 Jul 28.

PMID:
25074436
20.

Supplemental Content

Support Center